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Activity-Dependent mRNA Splicing Controls
ER Export and Synaptic Delivery of NMDA Receptors
And yet, little is known about the molecular mechanisms
for trafficking NMDARs to and from synapses.
Prior to their arrival at the synapse, NMDARs are as-
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sembled cotranslationally in the endoplasmic reticulum2 Program in Cell and Molecular Biology
(ER) from an essential NR1 subunit along with one or3 Department of Cell Biology
more NR2 subunits. The NR1 subunit is encoded by a4 Department of Pharmacology and Cancer Biology
single gene with three alternatively spliced exons (Zukin5 Neuroproteomics Laboratory
and Bennett, 1995). One of them, exon 5, encodes anDuke University Medical Center
extracellular N-terminal domain, while exons 21 and 22Box 3209
encode intracellular C-terminal domains, called C1 andDurham, North Carolina 27710
C2, respectively. Exclusion of exon 22 by alternative
mRNA splicing introduces a new coding region that en-
codes an unrelated domain termed C2 (Zukin and Ben-
nett, 1995). Whereas exon 5 regulates the pharmacologi-Summary
cal properties of NMDARs (Zukin and Bennett, 1995),
mRNA splicing at exons 21 and 22 influences proteinActivity-dependent targeting of NMDA receptors
interactions and intracellular trafficking whose role in(NMDARs) is a key feature of synapse formation and
synaptic targeting has been uncertain (Ehlers et al., 1995,plasticity. Although mechanisms for rapid trafficking
1996, 1998; Okabe et al., 1999; Standley et al., 2000; Scottof glutamate receptors have been identified, the mo-
et al., 2001; Xia et al., 2001).lecular events underlying chronic accumulation or loss
Synaptic targeting of NMDARs is regulated by activity.of synaptic NMDARs have remained unclear. Here we
For example, in young hippocampal slice cultures, syn-demonstrate that activity controls NMDAR synaptic
aptic delivery of NR2A-containing NMDARs requires re-accumulation by regulating forward trafficking at the
ceptor activation (Barria and Malinow, 2002). In adultendoplasmic reticulum (ER). ER export is accelerated
hippocampal slice, long-term potentiation (LTP) at CA1by the alternatively spliced C2 domain of the NR1 sub-
synapses promotes the rapid surface expression ofunit and slowed by the C2 splice cassette. This mRNA
NMDARs and increases NMDAR currents (Grosshans etsplicing event at the C2/C2 site is activity dependent,
al., 2002). On the other hand, certain forms of long-termwith C2 variants predominating upon activity block-
depression (LTD) are accompanied by a rapid decreaseade and C2 variants abundant with increased activity.
in synaptic NMDARs (Heynen et al., 2000). Over muchThe switch to C2 accelerates NMDAR forward traf-
longer time scales of several days, blockade of neuronalficking by enhancing recruitment of nascent NMDARs
activity increases synaptic accumulation of NMDARsto ER exit sites via binding of a divaline motif within C2
and increases the amplitude of NMDAR-mediated minia-to COPII coats. These results define a novel pathway
ture excitatory postsynaptic currents (mEPSCs) (Rao andunderlying activity-dependent targeting of glutamate
Craig, 1997; Liao et al., 1999; Watt et al., 2000; Crumpreceptors, providing an unexpected mechanistic link
et al., 2001). Conversely, chronically elevated activitybetween activity, mRNA splicing, and membrane traf-
decreases the number of synaptic NMDARs and the sizeficking during excitatory synapse modification.
of NMDAR-mediated currents (Rao and Craig, 1997; Liao
et al., 1999; Watt et al., 2000; Crump et al., 2001). ByIntroduction
reciprocally regulating the number of synaptic receptors,
prolonged changes in neuronal activity scale NMDAR-
Experience modifies neural circuitry by use-dependent
mediated currents proportionally with AMPAR-mediated
changes in the number and function of glutamate recep- currents (Watt et al., 2000), providing a cellular mecha-
tors at excitatory synapses (Carroll and Zukin, 2002; nism for synaptic homeostasis and a likely basis for
Malinow and Malenka, 2002; Wenthold et al., 2003). metaplasticity—long-term alteration in the ability of a
Among the glutamate-gated ion channels, N-methyl- synapse to undergo subsequent potentiation or depres-
D-aspartate (NMDA) receptors (NMDARs) play a central sion (Abraham and Bear, 1996; Turrigiano and Nelson,
role in synapse formation, synaptic plasticity, and neuro- 2000).
psychiatric disease (Cull-Candy et al., 2001). A principal Although it was one of the very first examples of regu-
mechanism controlling NMDAR signaling is accurate lated glutamate receptor trafficking (Rao and Craig, 1997),
regulation of the number of NMDARs present at the the molecular and cellular mechanisms underlying long-
synapse (Carroll and Zukin, 2002; Wenthold et al., 2003). term activity-dependent synaptic targeting of NMDARs
Although recent studies have focused on the trafficking remain poorly understood. Blockade-induced accumu-
of AMPA-type glutamate receptors (AMPARs) (Malinow lation of synaptic NMDARs is accompanied by an in-
and Malenka, 2002), dynamic regulation of the number crease in receptor surface expression (Crump et al.,
of postsynaptic NMDARs is increasingly recognized as 2001), suggesting activity-dependent delivery to the
an integral feature of synapse maturation and synaptic plasma membrane. Moreover, in some cases, experience-
plasticity (Carroll and Zukin, 2002; Wenthold et al., 2003). dependent NMDAR targeting requires protein synthesis
(Quinlan et al., 1999), suggesting regulation at the level of
transcription, translation, or mRNA processing. NMDAR*Correspondence: ehlers@neuro.duke.edu
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subunits themselves contain molecular determinants for creased (TTX, 59%  11%; AP5, 44%  7%; Figures
1B and 1C). Conversely, increasing neuronal activityendocytosis (Roche et al., 2001), synapse association
(Barria and Malinow, 2002), scaffold interactions (Went- (Bicuc, 40 M, 48 hr) caused an inverse change in NR1
splice variants, namely an increase in expression ofhold et al., 2003), kinase-induced insertion (Lan et al.,
2001; Scott et al., 2001), and surface expression (Okabe C2-containing NR1 subunits (165%  15%) and a de-
crease in C2-containing NR1 (61%  6%) (Figures 1Bet al., 1999; Standley et al., 2000; Scott et al., 2001; Xia
et al., 2001), whose relative contributions to synaptic and 1C). NMDAR blockade did not itself affect firing
frequency in these cultures (control, 0.47 0.08 Hz, ntargeting remain unclear. The recent findings that
C-terminal domains of the NR1 subunit regulate NMDAR 11; AP5, 0.43 0.11 Hz, n 7), indicating that activation
of NMDARs is required for the activity-induced changessurface expression (Okabe et al., 1999), ER-to-Golgi se-
cretory trafficking (Standley et al., 2000; Scott et al., in NR1 splice variants. Importantly, these reciprocal
changes in NR1 splice variant expression occurred with-2001; Xia et al., 2001), and LTP-dependent surface deliv-
ery (Grosshans et al., 2002) point to the possibility for out changes in the total amount of NR1 protein (NR1-
pan, percent relative to control: TTX, 101%  5%; AP5,activity-regulated forward trafficking of NMDARs through
the secretory pathway. Notably, export from the ER is 112%  7%; bicuculline, 97%  2%; Figures 1B and
1C). Thus, activity regulates isoform composition butthe rate-limiting step for nearly all membrane proteins
to reach the cell surface (Lodish, 1988), and such export not overall expression of NR1.
To determine whether activity regulates NR1 spliceis mediated by COPII coats that bud vesicles from the
ER for transport to the Golgi (Barlowe, 2002). Yet, little variants at the mRNA level, we performed RNase protec-
tion assays using pan-NR1 and C2-specific probes (Fig-is known about how neuronal activity impinges on the
biogenesis and forward trafficking of any neurotransmit- ure 1A) to quantitatively measure NR1 mRNA isolated
from cortical neurons after chronic manipulations of ac-ter receptor or ion channel.
In this study, we have investigated the effect of activity tivity. Consistent with our results above (Figures 1B and
1C), prolonged activity blockade increased C2-con-on forward trafficking of NMDARs through the early se-
cretory pathway and the regulation of such trafficking by taining NR1 mRNA (percent relative to control: TTX,
208%  19%; and AP5, 189%  3%; Figures 1D andmRNA splicing. Using a combination of biochemical, im-
munocytochemical, and electrophysiological approaches, 1E). On the other hand, C2-containing NR1 mRNA was
reduced with increased activity (Bicuc, 79%  5%, Fig-we demonstrate that newly synthesized NMDARs un-
dergo accelerated transport between the ER and the ures 1D and 1E). This activity-dependent regulation of
NR1 mRNA splicing was reversible upon drug washoutplasma membrane in the absence of synaptic activity.
This hastened export from the ER arises due to altered (Figure 1E) and, as with total NR1 protein (Figure 1C),
total NR1 mRNA was unaffected by activity (Figure 1D),splicing of NR1 mRNA at exon 22 and incorporation of
an export signal that recruits nascent NMDARs to COPII- indicating no net effect on NR1 gene expression. Since
the expression of C2- or C2-containing NR1 splice vari-coated vesicles budding from the ER. These results
identify activity-dependent mRNA splicing and ER ex- ants is determined by inclusion or exclusion of a single
exon (Figure 1A), these findings provide direct evidenceport as a novel mechanism for bidirectional regulation
of NMDAR targeting to the synapse, revealing a potential that splicing at exon 22 of the NR1 pre-mRNA is deter-
mined by the level of neuronal activity.mechanism for synaptic homeostasis and metaplasticity.
Results Bidirectional Accumulation of NR1 Splice Variants
in the Postsynaptic Density
To test whether activity-dependent NR1 mRNA splicingActivity Regulates NR1 mRNA Splicing
at the C2/C2 Site resulted in corresponding changes in synaptic NMDARs,
postsynaptic density (PSD) fractions were isolated fromC-terminal splice variants of NR1 are differentially ex-
pressed at the cell surface (Okabe et al., 1999). To test cultured cortical neurons after 48 hr of activity blockade
(2 M TTX) or enhanced excitatory activity (40 M bicu-whether activity-dependent NMDAR targeting involves
NR1 C-terminal domains, we first examined the influ- culline), and the abundance of NR1 splice variants was
measured using domain-specific antibodies (Figure 2A).ence of neuronal activity on NR1 mRNA splicing (Figure
1A). Expression of C2- and C2-containing NR1 subunits Consistent with previous results (Rao and Craig, 1997;
Liao et al., 1999; Watt et al., 2000; Crump et al., 2001;from cultured cortical neurons (DIV 12–14) was mea-
sured following prolonged increases or decreases in Ehlers, 2003), prolonged activity blockade caused an
accumulation of NMDARs in the PSD (NR1-pan, TTX,activity using splice variant-specific antibodies. Neu-
ronal activity was decreased by blocking action poten- 181%18% relative to control, Figure 2B). Interestingly,
this synaptic accumulation was accompanied by atials using the Na channel blocker tetrodotoxin (TTX,
2 M) and increased by blocking inhibitory synaptic quantitatively similar accumulation of C2-containing
NR1 subunits in the PSD (TTX, 217% 20%, Figures 2Ainputs with the GABAA receptor antagonist bicuculline
(Bicuc, 40 M). Upon chronic activity blockade (TTX, 2 and 2B). Likewise, in PSD fractions from active cultures,
NMDARs were decreased in abundance (NR1-pan, Bi-M, 48 hr) or selective antagonism of NMDARs (D-AP5,
100 M, 7 days), conditions that result in synaptic accu- cuc, 65%  19% relative to control) and this decrease
was mirrored by a reduction of C2-containing NR1 sub-mulation of NMDARs (Rao and Craig, 1997; Liao et al.,
1999; Crump et al., 2001), the expression of C2-con- units (Bicuc, 16%  13%, Figures 2A and 2B). In con-
trast, C2-containing NR1 splice variants had a preciselytaining NR1 increased approximately 2-fold (percent rel-
ative to control: TTX, 167%  9%; AP5, 224%  10%; opposite pattern of synaptic accumulation, exhibiting
decreased PSD levels upon activity blockade (TTX,Figures 1B and 1C), whereas C2-containing NR1 de-
Activity Controls NMDAR ER Export by mRNA Splicing
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Figure 1. Activity Regulates NR1 mRNA
Splicing at Exon 22
(A) Top: Partial diagram of the NR1 gene
showing the intron/exon structure of C-ter-
minal splice variants. Exon 22 encodes the
C2 C-terminal domain of NR1. Exclusion of
exon 22 produces an alternate C-terminal
amino acid-encoding sequence termed C2.
Asterisks indicate stop codons in C2 and C2
domains. Amplified sequences used as
probes for RNase protection assays are
shown. Dark bars and numbers indicate
transmembrane domains. Bottom: Sche-
matic diagram of the NR1 subunit and its
C-terminal splice variants. The full-length
NR1 polypeptide is shown on the left. The
intracellular C termini are shown on the right.
Note that all NR1 subunits contain either C2
or C2.
(B) Activity blockade increases C2-con-
taining NR1 subunits and decreases C2-con-
taining NR1 subunits. Immunoblot analysis
was performed on total protein homogenates
from cultured cortical neurons (DIV 12–14).
Prior to analysis, cortical neurons were incu-
bated with TTX (2 M, 2 days), AP5 (100 M
D-AP5, 7 days), or bicuculline (Bicuc, 40 M,
2 days). Domain-specific antibodies were used
to measure the expression of total NR1 (NR1-
pan), C2-containing NR1 subunits (NR1-C2),
and C2-containing NR1 subunits (NR1-C2).
(C) NR1 splice variant protein levels in cortical
neurons incubated in TTX, bicuculline, or AP5
as in (B) were quantified by phosphorimager
analysis and normalized to control neurons.
Plotted data represent means  SEM from
four separate experiments. *p  0.01, **p 
0.001 relative to control, t test.
(D) Activity reversibly regulates NR1 splice
variants at the mRNA level. RNase protection
assays were performed on total RNA isolated
from control, TTX-, bicuculline-, or AP5-
treated cortical neurons as in (B) before or after a subsequent 2 day period of drug washout. Total NR1 (NR1-pan) and exon 22-excluded
(C2-containing, NR1-C2) NR1 transcripts were simultaneously detected using specific probes as indicated in (A).
(E) Quantitative analysis of NR1 mRNAs. The plotted data represent the ratio of exon 22-lacking (C2-containing) NR1 mRNA to total NR1
mRNA in drug-treated neurons relative to control neurons (means  SEM from four separate experiments, *p  0.05 relative to control, t test).
24% 18% relative to control) and increased PSD levels differentially regulate NMDAR forward trafficking. In ini-
tial experiments, the C2 or C2 domain of NR1 was fusedwith elevated activity (Bicuc, 197%  10%, Figures 2A
to the intracellular C terminus of Tac, a type I transmem-and 2B). Notably, addition of AP5 (100 M) and CNQX
brane protein that has been widely used to study mem-(10 M), antagonists of NMDARs and AMPARs, respec-
brane protein trafficking (Figure 3A; Standley et al., 2000;tively, mimicked the effect of TTX even in the presence
Roche et al., 2001; Scott et al., 2001), and these recombi-of bicuculline (Figures 2A and 2B), indicating a require-
nant fusions were expressed in COS-7 cells. At steadyment for postsynaptic glutamate receptor activation.
state, Tac is present as both a low molecular massMoreover, much like the slow kinetics of activity-depen-
immature species sensitive to endoglycosidase H (endodent synaptic NMDAR accumulation (Rao and Craig,
H) and as a higher molecular mass mature species resis-1997; Liao et al., 1999; Watt et al., 2000; Crump et al.,
tant to endo H that has traversed the medial Golgi (Figure2001; Ehlers, 2003), the bidirectional change in synaptic
3A; Standley et al., 2000; Roche et al., 2001; Scott etNR1 splice variants occurred slowly and reversed com-
al., 2001). Insertion of the C2 domain at the Tac Cpletely upon drug washout (Figures 2C and 2D). These
terminus increased the endo H-resistant fraction atexperiments show that activity-dependent synaptic tar-
steady state (82% 1%) compared to Tac alone (56%geting of NMDARs is accompanied by selective accu-
2%, Figures 3A and 3B). Conversely, insertion of C2mulation of C2-containing NR1 splice variants in the PSD.
resulted in a decrease in the endo H-resistant fraction
(14%  2%, Figures 3A and 3B). These steady-state
The C2 Domain Accelerates and the C2 Domain results suggested that the C2 domain facilitates,
Slows Forward Trafficking whereas the C2 domain hinders, maturation of Tac fu-
The marked synaptic accumulation of C2-containing sion proteins between the ER and Golgi.
NMDARs upon activity blockade (Figure 2) led us to To directly measure the kinetics of receptor trafficking
through the ER and Golgi, newly synthesized Tac fusionsinvestigate whether the C2 and C2 domains of NR1
Neuron
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Figure 2. Activity-Dependent Accumulation
of NR1 Splice Variants in the Postsynaptic
Density
(A) Immunoblot analysis of NR1 splice vari-
ants in postsynaptic density (PSD) fractions
isolated from control (Ctrl), TTX-, bicuculline
(Bicuc)-, or Bicuc plus D-AP5 and CNQX-
treated cortical neurons. PSD fractions were
resolved by SDS-PAGE and probed for total
NR1 (NR1-pan) or for NR1 splice variants con-
taining C2 (NR1-C2) or C2 (NR1-C2) do-
mains.
(B) Quantitative analysis of total NR1 (NR1-
pan) and NR1 exon 22 splice variants (C2/
C2) in the PSD. Data represent meansSEM
of PSD levels relative to control (n  4).
(C) Time course and reversibility of NR1 splice
variant accumulation or loss in the PSD. Cor-
tical neurons were incubated for various
times (numbers in hours) with TTX or bicucul-
line (Bicuc), or with subsequent 48 hr drug
washout (96 hr time points), prior to PSD iso-
lation and immunoblot analysis for NR1-C2
or NR1-C2.
(D) Activity causes a slow, bidirectional, and
reversible switch in synaptic NR1 splice vari-
ants. Data represent means  SEM of C2/
C2 ratios in PSD fractions isolated from TTX-
or bicuculline-treated cortical neurons rela-
tive to untreated controls (n  4).
were 35S-labeled and their endo H sensitivity was moni- rates (Huh and Wenthold, 1999), indicating that the dif-
ferential loss of radiolabel is due to a difference in thetored over time. Tac itself exhibited relatively rapid ac-
quisition of endo H resistance, with 46%  1% and kinetics of surface delivery of the two NR1 isoforms.
These data provide strong evidence for opposing effects61%  2% achieving endo H resistance after 60 min
and 120 min, respectively (Figures 3C and 3D). Insertion of C2 and C2domains on the kinetics of forward traffick-
ing and indicate that C2 facilitates surface expressionof the NR1 C2 domain caused a marked slowing of
forward trafficking, with only 7%  1% and 15%  1% of NMDARs by accelerating transport between the ER
and Golgi.of Tac-C2 becoming endo H resistant after 60 min and
120 min chase, respectively (Figures 3C and 3D). On the
other hand, appending the C2 domain to Tac dramati- The C2 Domain of NR1 Contains a Novel ER
Export Signalcally accelerated the rate of Tac maturation (70%  2%
and 78%  1% mature species after 60 min and 120 To identify the molecular signal within C2 that enhances
ER export, we performed deletion analysis of the C2min chase, respectively; Figures 3C and 3D), indicating
that C2 and C2 domains serve as positive and negative domain. We concentrated on terminal residues impli-
cated in receptor surface expression (Standley et al.,signals for forward trafficking, respectively.
In order to compare the forward trafficking rates of 2000; Scott et al., 2001). Removal of the last three amino
acids of C2 (TVV) dramatically decreased the steady-endogenous C2- and C2-containing NMDARs, we met-
abolically labeled newly synthesized receptors in corti- state abundance of mature endo H-resistant Tac-C2
(Tac-C2, 82% 1%; Tac-C2TVV, 37% 2%; Figurescal neuron cultures and then measured the time-depen-
dent appearance of labeled receptors at the cell surface 4A and 4B), indicating an impairment in forward traffick-
ing. Indeed, monitoring of the kinetics of endo H resis-by examining their proteolytic sensitivity to extracellu-
larly applied chymotrypsin (Crump et al., 2001; Grosshans tance revealed a marked slowing of Tac-C2 maturation
when the terminal TVV motif was deleted (Figures 4Cet al., 2002), followed by immunoprecipitation with C2-
or C2-specific antibodies. The fraction of remaining in- and 4D), establishing the TVV divaline motif of C2 as a
bona fide ER export signal (Barlowe, 2002). Interestingly,tracellular NR1 that contained C2 was quantified from
the relationship (C2int/C2int  C2int) (Figure 3E). Based Tac-C2TVV displayed maturation kinetics similar to
Tac alone (endo H-resistant fraction: Tac, 46%  1%on this calculation, if the forward trafficking rate of C2-
and C2-containing NMDARs were equal, the fraction of at 60 min and 61%  2% at 120 min; Tac-C2TVV,
44% 1% at 60 min and 60% 3% at 120 min; compareintracellular NR1 containing C2 should remain constant
over the complete chase period. However, we observed Figures 3D and 4D), indicating that the enhancement of
forward trafficking by C2 was largely, if not exclusively,a marked decrease in the C2int/C2int  C2int ratio over
a 4 hr chase, indicating more rapid acquisition of chymo- due to the TVV motif.
To test whether the divaline-based ER export motiftrypsin sensitivity (and thus more rapid surface delivery)
of C2-containing NMDARs (Figure 3F). Importantly, of C2 regulates surface expression of NMDARs, we co-
expressed NR1 and NR2B subunits in COS-7 cells andNR1-C2 and NR1-C2 display no difference in turnover
Activity Controls NMDAR ER Export by mRNA Splicing
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Figure 3. ER-to-Golgi Forward Trafficking Is
Enhanced by C2 and Slowed by C2
(A) C2 increased while C2 decreased the
steady-state levels of mature Tac fusion pro-
tein. Endo H sensitivity was measured by
deglycosylation of COS-7 cell lysates ex-
pressing Tac, Tac-C2, or Tac-C2 prior to
immunoblot analysis. Diagrams of Tac-NR1
receptors are shown (top). The arrow desig-
nates mature endo H-resistant Tac species
(bottom). The arrowhead indicates immature
forms of Tac that are endo H sensitive and
thus have not reached the medial Golgi.
(B) Quantification of the percent endo H-resis-
tant Tac species from (A) indicates inverse
effects of C2 and C2 domains on steady-
state levels of mature receptor. Plotted data
represent means  SEM from three separate
experiments, **p  0.001 relative to Tac
alone, t test.
(C) The C2 domain promotes whereas the
C2 domain slows ER export. ER-to-Golgi
transport of newly synthesized Tac receptors
was monitored by 35S-pulse-chase followed
by endo H deglycosylation of labeled Tac im-
munoprecipitates and autoradiography. Arrow
and arrowhead as in (A).
(D) The rate of ER-to-Golgi transport is in-
creased by C2 and decreased by C2. Plotted
data represent means  SEM of the percent
endo H-resistant Tac receptor from (C) at var-
ious times of chase (n  3). **p  0.001, *p 
0.05 relative to Tac alone, t test.
(E) Surface delivery kinetics of endogenous
NR1 splice variants in neurons. Cortical neu-
rons (DIV 12) were labeled with 35S-methio-
nine/cysteine and chased in unlabeled media
for the indicated times, and surface proteins
were digested with chymotrypsin prior to sol-
ubilization and immunoprecipition for NR1-
C2 or NR1-C2. Remaining intracellular C2-
and C2-containing NMDARs were visualized
by autoradiography. Loss of label indicates
progressive appearance of NMDARs at the cell surface where they become accessible to chymotrypsin.
(F) Endogenous C2-containing NMDARs reach the neuronal cell surface more rapidly than C2-containing NMDARs. Plotted data represent
means  SEM of the fraction of remaining intracellular NR1 subunits that contain C2 (C2int/C2int  C2int). The decreasing C2int/C2int  C2int
ratio over time indicates more rapid surface delivery for C2-containing receptors.
assayed plasma membrane levels by surface biotinyla- deleted (surface/total ratios: 0.77  0.06, GFP-NR1-4;
0.51  0.10, GFP-NR1-4TVV; Figure 4I). These resultstion (Figure 4E). Deletion of the TVV ER export motif
caused a significant reduction in surface-expressed expand previous work (Okabe et al., 1999; Standley et al.,
2000; Scott et al., 2001; Xia et al., 2001) by showing thatNR1/NR2B heteromers (NR1-4/NR2B, 52.9%  0.4% at
the surface; NR1-4TVV/NR2B, 35.5%  0.7%; Figure the C2 domain contains an intrinsic ER export motif that
accelerates forward trafficking of NR1 and thereby en-4F), consistent with reduced ER export. To determine
whether the ER export motif of C2 likewise regulated hances the steady-state surface expression of NMDARs.
NR1 surface expression in neurons, full-length GFP-
tagged NR1-4 was expressed in hippocampal neurons The Divaline Motif of NR1-C2 Binds COPII
and Recruits Receptors to ER Exit Sitesand surface receptors were labeled with anti-GFP anti-
body. Immunofluorescent microscopy revealed that ER export requires recruitment of membrane proteins
to ER exit sites, where COPII coats bud off vesiclesGFP-NR1-4 was robustly expressed at the neuronal cell
surface, appearing in puncta throughout the soma and destined for the Golgi (Barlowe, 2002). To test whether
the C2 domain actively recruits nascent receptors to ERdendrites (Figure 4G), where it localized to glutamatergic
synapses (data not shown). A qualitatively similar pat- exit sites, we took advantage of a temperature-sensitive
mutant of the vesicular stomatitis virus glycoproteintern was observed for GFP-NR1-4TVV (Figure 4H).
However, the intensity of surface GFP-NR1-4TVV puncta (VSVG-ts045) tagged with spectral variants of green flu-
orescent protein (VSVG-YFP) (Lippincott-Schwartz etwas notably less than that for wild-type NR1-4 (Figures
4G and 4H). Indeed, quantitative fluorescence measure- al., 2000) and selective temperature block of ER exit
(Mezzacasa and Helenius, 2002). At the nonpermissivements revealed a significant decrease in the ratio of
surface to total NR1 when the TVV ER export motif was temperature (39.5C), VSVG-YFP is misfolded and re-
Neuron
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Figure 4. A Divaline-Based ER Export Motif in C2 Facilitates NMDAR Surface Delivery
(A) Deletion of the TVV motif in C2 (Tac-C2) decreased the steady-state levels of mature Tac fusion protein. Endo H sensitivity was measured
by deglycosylation of COS7 cell lysates expressing Tac-C2 or Tac-C2TVV prior to immunoblot analysis. Arrow and arrowhead as in Figure 3A.
(B) Means  SEM of the percent mature Tac species from (A). n  3, **p  0.001 relative to Tac-C2, t test.
(C) The TVV motif promotes ER export. ER-to-Golgi transport of newly synthesized Tac receptors was monitored by 35S-pulse-chase followed
by endo H deglycosylation of labeled Tac immunoprecipitates and autoradiography. Arrow and arrowhead as in (A).
(D) Increased rate of ER-to-Golgi transport in receptors containing the TVV motif. Plotted data represent means  SEM of the percent endo
H-resistant Tac receptor at various times of chase (n  3). **p  0.001 relative to Tac-C2, t test.
(E) The TVV ER export signal increases surface expression of full-length NMDARs. COS7 cells expressing NR1-4/NR2B or NR1-4TVV/NR2B
heteromeric NMDARs were surface biotinylated, and surface membrane proteins (S) were isolated by neutravidin pull-down. Both surface
membrane fractions (S) and total cell homogenates (T) were immunoblotted with anti-NR1 antibody.
(F) The ratio of surface/total NR1 from biotinylation experiments in (E) was quantified by phosphorimager analysis. Data represent means 
SEM. n  3, *p  0.05 relative to full-length NR1-4, t test.
(G and H) The TVV ER export signal increases synaptic delivery of NMDARs in hippocampal neurons. Hippocampal neurons (DIV 14) expressing
GFP-NR1-4 (G) or GFP-NR1-4TVV (H) were surface labeled with anti-GFP antibody prior to fixing and staining with fluorophore-conjugated
secondary antibody. Total GFP-NR1-4 was visualized by endogenous GFP fluorescence. Arrows indicate surface NR1 puncta. Boxed regions
in upper panels are magnified in lower panels. Scale bars equal 5 m (upper panels) and 2 m (lower panels).
(I) Quantification of GFP-NR1 surface expression in hippocampal neurons from (G) and (H). Data represent means  SEM of surface NR1/
total NR1 fluorescence ratios. n  7–8, *p  0.05 relative to full-length NR1-4, t test.
tained in the ER. Upon shift to the permissive tempera- little detectable localization to ER exit sites (Figure 5A,
middle panels). In contrast, appending the C2 domainture (32C or lower), VSVG-YFP correctly folds, exits the
ER, and traffics to the Golgi en route to the plasma to Tac caused a marked accumulation of receptors at
ER exit sites indicated by punctate VSVG-YFP labelingmembrane (Lippincott-Schwartz et al., 2000). This for-
ward traffic can be arrested at the stage of ER exit at 10C (Figure 5A, lower panels), consistent with the
more rapid export of Tac-C2 receptors (Figure 4).by switching from 39.5C to 10C, allowing functional
visualization of ER exit sites (Mezzacasa and Helenius, To investigate the mechanism underlying C2-depen-
dent recruitment to ER exit sites, we immobilized C22002). Using this approach, we found that after 10C
block, Tac receptors were abundant in the lacy ER mem- peptides on Sepharose 4B beads and tested whether
the C2ER export signal binds COPII. As shown in Figurebranes and showed modest accumulation at ER exit
sites (Figure 5A, upper panels). Likewise, Tac-C2 recep- 5B, the C2 peptide specifically pulled down the cargo
binding Sec23/24 bimolecular complex of COPII fromtors were present in the ER after 10C block with very
Activity Controls NMDAR ER Export by mRNA Splicing
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Figure 5. C2 Recruits Receptors to ER Exit
Sites by Binding COPII
(A) COS-7 cells expressing Tac, Tac-C2, or
Tac-C2 along with VSVG-YFP were incu-
bated at 39.5C for 18 hr and then switched
to 10C for 5 hr to allow protein accumulation
at ER exits sites prior to fixing and staining for
Tac (left). Punctate accumulations of VSVG-
YFP (arrowheads and arrows) indicate ER exit
sites. Arrows indicate colocalization of Tac-
C2 with VSVG-YFP. Insets are the higher
power images of the boxed region showing
the accumulations of Tac-C2 at VSVG-YFP
labeled ER exit sites. Scale bars equal 5 m
(large panels) and 1 m (insets).
(B) The divaline motif of C2 binds the Sec23/
Sec24 complex of COPII coats. Pull-downs
were performed on COS-7 cell lysates (input)
using unconjugated control beads (Ctrl), C2
peptide affinity resin (C2), or VV-AA mutant
C2 peptide affinity resin (C2 VV-AA), fol-
lowed by immunoblot detection with anti-
Sec23 antibody. Peptide sequences are
shown on the right.
(C) Direct binding of C2 to COPII coats. COPII
pull-down assays were performed as in (B) in
the absence (C2) or presence (C2FF) of
2.5 mM ERGIC-53 C-terminal peptide (FF, se-
quence is shown on the right) to compete
for binding to Sec23/24. Immunoblot analysis
with an anti-Sec23 antibody was used to de-
tect the Sec23/24 complex of COPII coats
(left). The competing ERGIC-53 C-terminal
peptide disrupts the COPII-C2 binding inter-
action.
cell lysates. Substitution of alanines for the terminal va- mechanism for this accelerated trafficking. However, the
lines completely abolished COPII binding. To confirm a C-terminal TVV of C2 has also been found to bind PDZ-
direct interaction between C2 and COPII, a peptide domain-containing proteins (Standley et al., 2000). In
representing the C-terminal sequence of ERGIC-53 (Fig- order to determine which interaction—COPII or PDZ—
ure 5C) was included in the pull-down assay. This pep- was responsible for the accelerated forward trafficking
tide contains a diphenylalanine motif that is known to of C2-containing proteins, we expressed various mu-
bind to cargo recognition sites on the Sec24 subunit tants of the C2 C terminus and determined the steady-
of Sec23/24 (Kappeler et al., 1997; Miller et al., 2003). state maturation of Tac-C2 fusion proteins using endo
Inclusion of excess ERGIC-53 peptide in the pull-down H sensitivity assay (Figures 6A and 6B). Substitution of
assay prevented the interaction between the immobi- the 	2 threonine with arginine (RVV), a mutation pre-
lized C2 peptide and Sec23/24 (Figure 5C), supporting dicted to disrupt type I PDZ interactions while leaving
competition for the same binding site. From these re- the COPII interaction intact (Morais Cabral et al., 1996;
sults, we conclude that the divaline ER export signal Songyang et al., 1997; Nufer et al., 2002), had no effect
recruits receptors to ER exit sites by directly binding on endo H sensitivity (82% 1% endo H-resistant, Tac-
COPII. C2; 85%  2.2%, Tac-C2 RVV; Figures 6A and 6B).
However, substitution of alanines for the terminal diva-
line motif (TAA), a mutation predicted to disrupt bothInteraction with COPII Mediates the Accelerated
PDZ interactions and COPII interactions (Figure 5), de-Trafficking of C2
creased the steady-state endo H-resistant pool of Tac-In pulse-chase experiments, accelerated forward traf-
C2 to 55%  2% (Figures 6A and 6B), a value identicalficking of Tac-C2depended on the C-terminal TVV motif
to Tac alone (compare to Figure 3B). To reduce COPIIof C2 (Figures 4C and 4D). Our findings indicate that
binding without affecting PDZ interactions, we substi-the terminal divaline motif of C2 directly binds compo-
nents of the COPII coat (Figure 5), providing a possible tuted arginine for the 	1 valine (TRV). This mutation
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Figure 6. The ER Export Function of C2 Is
through COPII Binding and not PDZ Interac-
tions
(A and B) Disruption of PDZ binding has no
effect on the steady-state levels of mature
Tac-C2. (A) The endo H sensitivity of Tac-
C2, Tac-C2 TAA, Tac-C2 RVV, or Tac-C2
TRV was measured as in Figure 3A. Arrow
and arrowhead as in Figure 3A. (B) Quantifica-
tion of the percent endo H-resistant Tac spe-
cies from (A). n 3, *p 0.01 relative to Tac-
C2, t test.
(C and D) Disruption of the PDZ binding motif
did not change the kinetics of ER-Golgi traf-
ficking of Tac-C2. (C) ER-to-Golgi transport
of newly synthesized Tac-C2 TAA, Tac-C2
RVV, or Tac-C2 TRV receptors was moni-
tored by 35S-pulse-chase as in Figure 3C.
Arrow and arrowhead as in (A). (D) Plotted
data represent means  SEM of the percent
endo H-resistant Tac receptor from (C) at var-
ious times of chase (n  3).
partially disrupted the divaline motif and correspond- M) were 35S-labeled, and the cell surface appearance of
NMDARs over time was measured using surface biotiny-ingly caused a partial decrease in the mature pool of
Tac-C2 (Figure 6B). lation followed by sequential neutravidin/anti-NR1 pre-
cipitation. Under control conditions, 19.9%  1.6% ofTo measure the effect of selectively disrupting PDZ
versus COPII interactions on forward trafficking rates, newly synthesized NMDARs reached the cell surface
within 12 hr (Figures 7A and 7B). This basal rate of surfacewe performed pulse-chase experiments. Monitoring endo
H resistance using 35S-pulse-chase analysis revealed delivery was markedly increased by activity blockade
(TTX, 30.1%  1.4% after 12 hr; Figures 7A and 7B),that the RVV mutation (and presumed disruption of PDZ
interactions) did not slow forward trafficking of Tac-C2 consistent with the fact that these neurons preferentially
express C2-containing NR1 subunits (Figures 1 and 2). In(Figures 6C and 6D, compare with Figure 3D). However,
the VV to AA substitution slowed the forward trafficking contrast, cortical neurons experiencing elevated activity
showed a substantial reduction in NMDAR surface deliv-kinetics of Tac-C2 to a rate similar to Tac alone. Substi-
tution of only the penultimate valine with arginine (TRV) ery rate (Bicuc, 14.1% 0.3% after 12 hr; Figures 7A and
7B), consistent with exclusion of the C2ER export motif.had an intermediate effect on trafficking kinetics, as
expected from the steady-state results (Figures 6A and To further establish the bidirectional effect of activity
on the forward trafficking of NMDARs, we used whole-6B). Together, these experiments show that the terminal
valine in C2 is critical for accelerated forward transport. cell recordings to measure the kinetics of NMDAR sur-
face delivery in hippocampal neurons. We took advan-The sufficiency of the divaline motif to facilitate forward
transport in the absence of an intact PDZ binding motif tage of the irreversible open channel blocker MK-801
and measured the recovery of NMDAR-mediated cur-strongly supports our model that COPII interactions,
rather than PDZ interactions, mediate the accelerated rents after complete MK-801 block. Under these condi-
tions, current recovery reflects the delivery of new intra-forward trafficking of C2-containing NMDARs.
cellular NMDARs to the cell surface (Lan et al., 2001).
Basal whole-cell NMDAR-mediated currents were evokedActivity Bidirectionally Regulates the Surface
Delivery Rate of NMDARs by NMDA application (Figure 7C, left), and surface NMDARs
were then blocked by simultaneous application ofThe number of synaptic NMDARs is reciprocally regu-
lated by neuronal activity (Rao and Craig, 1997; Liao et NMDA and MK-801 (20 M) (Figure 7C, second current
trace). After MK-801 block, currents evoked by NMDAal., 1999; Watt et al., 2000; Crump et al., 2001). Our findings
that activity regulates NR1 mRNA splicing at exon 22 were recorded every 10 min in response to NMDA appli-
cation (Figure 7C). In control neurons, the amplitude of(Figures 1 and 2) and thereby controls the inclusion or
exclusion of an ER export motif in C2 (Figures 3–6) sug- NMDA-evoked currents progressively recovered follow-
ing MK-801 block, reaching 4.9%  1.7% of the initialgest that activity may regulate accumulation of NMDARs
at synapses by regulating trafficking at the level of the amplitude after 1 hr (n 5, Figure 7D). In neurons treated
for 48 hr with TTX or bicuculline, NMDAR currents alsoER. To test this hypothesis, we measured the effect of
activity on the rate at which newly synthesized NMDARs recovered, but the rate of recovery was altered ac-
cording to activity level. In TTX-treated neurons, NMDARreached the cell surface. Cortical neurons treated for
48 hr with control solution, TTX (2 M), or bicuculline (40 current recovery was nearly twice as rapid, reaching
Activity Controls NMDAR ER Export by mRNA Splicing
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Figure 7. NMDAR Surface Delivery Rate Is
Controlled by Activity Level
(A) Pulse-chase biotinylation assays of
NMDAR surface delivery were performed on
control, TTX-, and bicuculline-treated cortical
neurons (see Experimental Procedures). The
amount of 35S-labeled NR1 appearing at the
cell surface (surface NR1) after various times
of chase provides a measure of forward traf-
ficking rate.
(B) Quantitative analysis of NMDAR surface
delivery. The percent of 35S-labeled NR1 sub-
units at the cell surface measured by phos-
phorimager analysis was plotted as a function
of time (means SEM, n 3, *p 0.05, **p
0. 01 relative to control at the same time point,
t test).
(C) Measurement of NMDAR insertion by re-
covery from MK-801 block. A representative
sequence of whole-cell currents evoked by
NMDA application (500 M) is shown. Re-
cordings were made from hippocampal neu-
rons (DIV 9–22) voltage-clamped at 	40 mV.
After complete block by MK-801 (20 M; sec-
ond current trace), NMDA currents gradually
recovered over 60 min, indicating the appear-
ance of new NMDARs (rightmost current
trace). Arrows indicate steady-state NMDA-
evoked currents. Inset at right shows the re-
covered NMDA-evoked current at an ex-
panded scale.
(D) Kinetics of NMDAR surface delivery mea-
sured by recovery from MK-801 block. Data
represent means  SEM of the steady-state
NMDA-evoked currents at various times after
MK-801 block normalized to the initial cur-
rents before MK-801 application. n  5, *p 
0.05 relative to control values at the same
time point, t test.
9.8%  1.7% (n  5) of basal currents after 60 min (Figures 8A and 8B), as well as a dramatic reduction in
the number of NMDAR puncta (27  4 NR1 puncta per(Figure 7D). In contrast, bicuculline-treated neurons
showed significantly slower recovery from MK-801 100m dendrite) compared with sister cultures express-
ing GFP alone (65  6 NR1 puncta per 100 m dendrite;blockade (2.4%  1.1% after 60 min, n  5; Figure
7D). These results indicate altered forward trafficking of Figure 8C). NR1 puncta in GFP-C2-expressing neurons
NMDARs in response to activity and are remarkably remained localized to excitatory synapses as indicated
consistent with the biochemical experiments above (Fig- by colocalization with the postsynaptic scaffold protein
ures 7A and 7B). Together, these data provide strong Shank (Figure 8A). Moreover, the effect of C2 peptide
evidence that chronic changes in neuronal activity regu- was specific for NMDARs, as the number of puncta
late both forward trafficking and membrane delivery positive for Shank remained unchanged (84  7 per
of NMDARs. 100 m dendrite for GFP, 71  7 for GFP-C2, p 
 0.05,
t test; Figure 8C). Further, expression of C2 peptides
lacking the divaline motif (GFP-C2TVV) had no effectThe NR1 C2 Domain Is Required for
on NMDAR clustering (data not shown). In all cases,Blockade-Induced Synaptic Targeting
NR1 and Shank puncta colocalized with markers of pre-To test whether the synaptic accumulation of NMDARs
synaptic terminals (data not shown). Likewise, in a sepa-upon activity blockade is due to C2-dependent forward
rate set of experiments, GFP-C2 had no effect on thetrafficking, we expressed a GFP-tagged soluble C2 pep-
density of synapsin puncta (synapsin puncta per 100tide to disrupt the interaction of NR1 with COPII coats.
m dendrite: GFP, 51  8; GFP-C2, 44  8, p 
 0.05,Hippocampal neurons expressing GFP-C2 were grown
t test), indicating no change in the number of synapticin the presence of AP5 (100M, 7 days) to induce NMNDR
contacts.clustering, and NMDAR clusters were visualized and
To further demonstrate that synaptic accumulation ofquantified by anti-NR1 staining. As shown in Figure 8,
NMDARs after activity blockade is due to C2-depen-expression of C2 peptide caused a decrease in the
fluorescence intensity of detectable NMDAR puncta dent forward trafficking, we measured the recovery from
Neuron
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Figure 8. The NR1 C2 Domain Is Required for Blockade-Induced Synaptic Accumulation of NMDARs.
(A) GFP or GFP-C2 was expressed in hippocampal neurons (DIV 21) grown in the presence of 100 M AP5 (7 days) to induce NMDAR
clustering. NR1 (red) and Shank (green) clusters were visualized by immunofluorescent staining. Expression of GFP-C2 caused a marked
reduction in the number of detectable NR1 puncta but had no effect on Shank staining (right). Note that the GFP-C2-transfected dendrite in
the right panels displayed decreased NR1 clusters relative to the dendrite of a neighboring untransfected neuron in the same field (long arrows
in NR1-stained panel). Short arrows indicate colocalized NR1/Shank clusters. Arrowheads indicate Shank puncta with no detectable NR1.
Dashed white boxes indicate dendritic regions shown at higher power in accompanying panels. Scale bars equal 5 m (upper panels) and 2
m (higher power images).
(B) Histogram of the distribution of fluorescence intensity of NR1 puncta. Note that expression of GFP-C2 decreases both the average
intensity and the number of NMDAR clusters. Arrows indicate the median value of fluorescence intensity.
(C) Means SEM of the number of NR1 or Shank puncta per 100 m dendrite from (A). n 6–7 neurons from sister cultures for each condition,
*p  0.05 relative to the value from GFP-expressing neurons, t test.
(D) Expression of C2 peptide decreases the insertion rate of NMDARs after activity blockade. Insertion rate of NMDARs in hippocampal
neurons (DIV 9–22) expressing C2 peptide after activity blockade (TTX, 1 M, 2 days) was measured by recovery from MK-801 block as in
Figure 7C. Data represent means  SEM of the steady-state NMDA-evoked currents at various times after MK-801 block normalized to the
initial currents before MK-801 application. n 3–4, *p 0.05 relative to the values from GFP-expressing neurons at the same time point, t test.
MK-801 block in neurons expressing GFP or GFP-C2 activity blockade, supporting a role for C2-mediated
ER export in NMDAR surface delivery. Finally, theseas in Figure 7C. After chronic TTX treatment (1 M, 48
hr), expression of GFP in neurons showed no effect on results provide further evidence indicating that inclusion
or exclusion of exon 22 in NR1 pre-mRNA is a key deter-NMDAR insertion rate as compared with TTX-treated,
nontransfected neurons, reaching 8.8%  1.5% (n  4) minant of NMDAR forward trafficking and synaptic tar-
geting during synaptic homeostasis.of basal currents after 60 min (compare Figures 8D and
7D). In contrast, expression of soluble GFP-C2 peptide
significantly decreased the insertion rate of NMDARs Discussion
with only 5.9%  0.9% recovery of basal currents after
60 min (n  3, p  0.05, t test; Figure 8D). Together, In the present study, we have demonstrated that activity
regulates NMDAR synaptic targeting through an unex-these data indicate that the C2 domain of NR1 regulates
the synaptic targeting of NMDARs following prolonged pected mechanism involving mRNA splicing and regu-
Activity Controls NMDAR ER Export by mRNA Splicing
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Figure 9. Proposed Model for Activity-Depen-
dent Synaptic Targeting of NMDARs
In this simplified model, prolonged synaptic
blockade results in (1) exclusion of exon 22
in NR1 mRNA leading to synthesis of NR1
subunits containing the C2 domain. (2) The
divaline ER export signal in C2 interacts with
COPII coats to recruit nascent receptors to
ER exit sites. (3) Recruitment to ER exit sites
facilitates ER export and thereby accelerates
forward trafficking of NMDARs. (4) As a result,
increased numbers of NMDARs are delivered
to the synapse. In contrast, a precisely oppo-
site sequence of events (inclusion of exon 22
and thus synthesis of NR1-C2, decreased ER
export, decreased surface accumulation) oc-
curs in response to increased neuronal ac-
tivity.
lated ER export. In response to prolonged activity block- tion or reduction in synaptic NMDARs is a direct conse-
quence of altered ER export. By regulating the kineticsade, exon 22 is excluded from NR1 mRNA, resulting in
the synthesis of NR1 subunits containing the alternate of NMDAR forward trafficking and thus the number of
synaptic NMDARs, the magnitude of NMDAR-mediatedC2 domain at the distal C terminus. The C2 domain
in turn contains a divaline-based ER export motif that signals can be tuned to the level of activity. In addition to
affecting basal transmission, control over the magnitudeenhances the export of newly synthesized NMDARs
from the ER by directly binding COPII coats at ER exit and duration of NMDAR-mediated signals is of funda-
mental importance for setting the synaptic modificationsites. As ER export is rate limiting, more rapid export
increases surface delivery and synaptic targeting of threshold for subsequent activity-dependent plasticity
(Abraham and Bear, 1996; Philpot et al., 2003). Surpris-NMDARs (Figure 9).
ingly, the mechanism revealed here for NMDARs is quite
distinct from that utilized by AMPARs, which accumulate
NMDAR ER Export, Homeostasis, at synapses upon prolonged activity blockade due to a
and Metaplasticity decrease in their rate of turnover (O’Brien et al., 1998).
Activity-dependent ER export of NMDARs may provide Thus, although the number of AMPARs and NMDARs
a cellular mechanism for synaptic homeostasis and may at the postsynaptic membrane scale in parallel (Watt et
determine the propensity of synapses to undergo poten- al., 2000), the scaling of these two classes of homolo-
tiation or depression—a process termed metaplasticity gous glutamate receptors is alternately regulated at the
(Abraham and Bear, 1996). In response to altered activity level of protein degradation and ER export, respectively.
over a period of days, excitatory synaptic strength at
glutamatergic synapses is scaled in a compensatory
manner, with mEPSC amplitudes increasing after pro- ER Export as an Activity-Regulated Checkpoint
Quality control in the ER is a key feature of ion channellonged blockade and decreasing after chronic synaptic
activation (Turrigiano et al., 1998; Watt et al., 2000; Desai biogenesis, proper stoichiometric assembly, and sur-
face expression and has been proposed to control theet al., 2002). This homeostatic plasticity occurs in neu-
ronal culture models (O’Brien et al., 1998; Turrigiano et overall number of channels at the cell surface (Ma et al.,
2001; Ellgaard and Helenius, 2003). To date, ER retentional., 1998; Lissin et al., 1999) and during critical periods
in vivo (Desai et al., 2002) and is thought to provide a and ER export have been considered intrinsic properties
of channel assembly caused by masking of ER retentioncountervailing mechanism to rapid forms of Hebbian
plasticity by ensuring that neurons remain in an optimal signals or exposure of ER export signals (Ma et al., 2001;
Greger et al., 2002). The possibility that export from thefiring frequency range (Turrigiano and Nelson, 2000).
Although the homeostatic changes in mEPSC ampli- ER can act as a regulated checkpoint sensitive to the
signaling needs of the neuron or prior history of activitytudes reflect synaptic AMPARs, NMDAR-mediated cur-
rents are scaled up or down by chronic changes in activ- has been postulated (Scott et al., 2001) but has remained
an open question. Here we have shown that activityity proportionally with AMPAR-mediated currents (Watt
et al., 2000). Indeed, prolonged visual experience and level directly regulates ER export of nascent NMDARs.
This switch in ER export rate provides a rheostat-likedeprivation alternately diminishes or enhances NMDAR-
mediated transmission in visual cortical neurons (Philpot feedback mechanism for adjusting the pool of NMDARs
available for surface expression or synaptic incorpo-et al., 2001, 2003). This activity-dependent regulation of
NMDAR-mediated currents is accompanied by corre- ration. Indeed, rapidly exported NMDARs containing
NR1-C2 exhibit higher basal surface expression (Okabesponding physical accumulation or loss of NMDARs
from the postsynaptic membrane (Rao and Craig, 1997; et al., 1999), and the presence of NR1-C2 versus NR1-
C2—slow and fast exported receptors, respectively—Liao et al., 1999; Crump et al., 2001; Ehlers, 2003). Here
we have shown that the activity-dependent accumula- exerts a significant effect on NMDAR potentiation by
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both PKC and tetanic stimulation (Lan et al., 2001; deed, substantial evidence implicates reversible protein
phosphorylation in spliceosome assembly and disas-Grosshans et al., 2002). Thus, ER export may be the first
of several NMDAR trafficking steps regulated by activity, sembly as well as splicing catalysis (Dredge et al., 2001;
Grabowski and Black, 2001). In this regard it is interest-in essence acting as a “master regulatory valve” for a
pipeline of NMDARs supplied for later exocytotic events. ing to note that activity-dependent synaptic targeting
of NMDARs is regulated by protein kinase pathwaysER exit is mediated by COPII-coated vesicles that bud
off from defined points on the ER membrane (Barlowe, (Crump et al., 2001; Fong et al., 2002), raising the intri-
guing possibility that neuronal splicing factors acting on2002). The packaging and concentrating of cargo into
budding COPII vesicles involves direct binding of export the NR1 pre-mRNA may be regulatory targets of these
kinase cascades. Further, while the splicing of exonsignals with the Sec24 subunit of the Sec23/24 complex
(Kappeler et al., 1997; Barlowe, 2002; Miller et al., 2003; 22 is regulated by activity, levels of NMDAR protein
containing exon 21 remain stable regardless of activityMossessova et al., 2003). Results provided here demon-
strate that the divaline motif of the NR1 C2 domain blockade (Rao and Craig, 1997). This high degree of
specificity in the exons subject to regulated splicinglikewise binds Sec23-Sec24, providing to our knowl-
edge the first demonstration of a COPII binding ER ex- suggests specific cis-acting elements within the exons
themselves or neighboring intronic sequences. Clearly,port motif in an ion channel. Consistent with our findings,
C-terminal valine residues facilitate ER export of type I it will be important for future studies to delineate the
relevant signaling pathways, molecular targets, andintegral membrane proteins (Nufer et al., 2002), sug-
gesting that direct COPII association may be a con- RNA elements between altered neuronal activity and
regulation of splicing at exon 22. More broadly, coordi-served mechanism across broad families of integral
membrane proteins. nation of mRNA splicing may provide a general mecha-
nism for activity-dependent modification of CNS syn-Interestingly, the positional requirement of COPII
binding valine motifs, namely at the very C terminus, is apses.
shared by type I PDZ binding motifs (T(S)XV), suggesting
that such motifs have dual functions—an initial ER ex-
Experimental Procedures
port function via COPII and a subsequent targeting func-
tion via a PDZ protein. For a number of plasma mem- Antibodies and DNA Constructs
brane proteins (Fernandez-Larrea et al., 1999; Standley Anti-Tac (Covance, 1:500), anti-GFP (Chemicon, 1:1000), anti-NR1
(S3C11, 1:250), and anti-Shank (a gift from Dr. Eunjoon Kim, 1:250)et al., 2000), surface expression has been thought to
antibodies were used for immunofluorescence. For Western blots orrely upon PDZ interaction. However, it is likely that broad
immunoprecipitations, anti-Tac (Santa Cruz Biotechnology, 1:1000),classes of type I PDZ binding motifs also interact with
anti-NR1(54.1, Pharmingen International, 1:1500), anti-C2 (1233,
COPII. In light of our findings, conclusions regarding 1:1000), anti-C2 (1683, 1:2000), or anti-Sec23 (a gift from Dr. Wanjin
trafficking mechanisms previously ascribed to PDZ in- Hong, 1:2000) antibodies were used.
teractions may warrant reexamination. Indeed, recent Generation of Tac-NR1 constructs was accomplished as pre-
viously described (Scott et al., 2001). For GFP-C2 construct, a pairreports have shown that terminal valine motifs in a vari-
of primers (5-GGTGTACAAGCAGTACCATCCCACTGATATCACG-3ety of contexts can accelerate forward trafficking (Nufer
and 5-ATTTGCGGCCGCTCAGCTGACCGAGGGATCTGAGAG-3)et al., 2002). We propose that many, if not all, type I PDZ
were used to amplify the C2 domain, which was then inserted into
binding motifs in integral membrane proteins also bind pEGFP-N1 (Clontech). VSVG-YFP was a generous gift from Dr. Kai
COPII in early phases of secretory trafficking. Simons. GFP-NR1 was kindly provided by Dr. Stefano Vicini. GFP-
NR1-4 TVV was generated by inserting a stop codon before Thr904
(in NR1-4b) using Stratagene’s Site-Directed Mutagenesis Kit fol-Activity-Dependent mRNA Splicing of NR1
lowing the manufacturer’s instructions.Brain-specific alternative splicing generates much of the
diversity needed in proteins involved in neurotransmis-
sion and nervous system development (Dredge et al., Cell Culture and Transfection
2001; Grabowski and Black, 2001). Indeed, numerous Hippocampal neurons, cortical neurons, and COS-7 cells were cul-
tured and transfected as previously described (Ehlers, 2000; Scottdevelopmental and region-specific changes in mRNA
et al., 2001).splicing have been documented throughout the nervous
system under both physiological and pathological con-
ditions (Dredge et al., 2001; Grabowski and Black, 2001), Metabolic Labeling and Endo H Resistance Assay
although the mechanisms regulating such splicing re- COS-7 cells, transfected for 48 hr, were washed three times with
Hank’s balance salt solution and starved for 30 min at 37C in DMEM/main almost completely unknown.
methionine/cysteine-free medium. Cells were then labeled with 500Results presented here support a direct link between
Ci/ml 35S-methionine/cysteine for 20 min and chased with condi-NR1 mRNA splicing, activity, and synaptic homeostasis.
tioned media supplemented with 2 M methionine for the timesIn particular, our findings suggest a signaling pathway
indicated. After chase, cells were washed with ice-cold PBS, lysed
whereby activation of NMDARs triggers a cascade that in lysis buffer (20 mM Tris 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
leads to inclusion of exon 22 in NR1 mRNA. In nonneu- X-100, protease inhibitor cocktail), and immunoprecipitated with an
anti-Tac antibody (2 g/IP). The immunoprecipitate was eluted inronal cells, extracellular stimuli and protein kinase acti-
30 l elution buffer (50 mM Tris 8.0, 1% SDS, 0.1% -mercaptoetha-vation alter the splicing of several transcripts (Grabow-
nol) by boiling for 5 min. The resulting elution was mixed with 30 lski and Black, 2001; Xie and Black, 2001) through poorly
of endo H digestion buffer (150 mM sodium citrate [pH 5.5], 2characterized cellular signaling pathways. In many
PMSF) and then divided into two equal aliquots. 50 mU of endo H
cases, the change in splicing is independent of new was added to one aliquot and incubated at 37C for 5 hr. The reaction
protein synthesis, indicating that a kinase or other en- was stopped by adding an equal volume of 2 SDS-PAGE load-
ing buffer.zyme may directly modify the splicing apparatus. In-
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Chymotrypsin Proteolysis 700A amplifier (Axon Instruments, Foster City, CA) controlled with
a Pentium PC running MultiClamp Commander 1.1 and pClamp 8.02Cortical neurons (9–10 DIV) were metabolically labeled with 500Ci/
ml 35S-cysteine/methionine and chased as described above. After (Axon Instruments). Signals were filtered at 4 kHz and sampled at
10 kHz. If the series resistance changed from initial value duringchase, neurons were washed with Hank’s balanced salt solution
and treated with 1 mg/ml chymotrypsin for 10 min at 37C. The recording, the recording was terminated or the data were discarded.
intracellular protected NR1 subunits were then immunoprecipitated
with anti-NR1 antibodies (1683 for C2-containing NR1, 1233 for C2- Acknowledgments
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